Dr. Lal Path Labs Current Share Price | Dr. Lal Path Labs Stock Screener
LALPATHLAB
Healthcare Service Provider
Dr. Lal Path Labs Current Stock Price Today
Live Share Price NSE
₹1896.90
▼
-27.80 (-1.44%)
Live Share Price BSE
₹1895.85
▼
-30.85 (-1.60%)
As of September 18, 2026, the live Dr. Lal Path Labs share price (NSE: LALPATHLAB) is ₹1,896.90 on NSE and ₹1,895.85 on BSE, down 1.44% from the previous close, with shares trading between ₹1,885.00 and ₹1,959.40 in today's trading session, and a 52-week range of ₹1,307.60–₹3,390.00.
Browse Dr. Lal Path Labs annual reports to support your investment research.
Use the Dr. Lal Path Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Dr. Lal Path Labs Market Cap
₹32,116.04 Cr.
LALPATHLAB P/E Ratio (TTM)
58.66
Dr. Lal Path Labs P/B Ratio
12.83
EPS (TTM)
₹30.24
Dividend Yield
1.07%
Debt to Equity
0.08
LALPATHLAB 52 Week High
₹3390.00
Dr. Lal Path Labs 52 Week Low
₹1307.60
Operating Margin
27.00%
Profit Margin
18.16%
LALPATHLAB Revenue (TTM)
₹727.00
EBITDA
₹211.00
Net Income
₹132.00
Total Assets
₹3,146.00
Total Equity
₹2,541.00
Dr. Lal Path Labs Current Share Price Chart
Track the current Dr. Lal Path Labs share price and stock price with an interactive chart. Analyse LALPATHLAB price trends, trading volume, historical performance, and volatility across different timeframes — the complete Dr. Lal Path Labs stock quote in one place.
Dr. Lal Path Labs Company Profile - Fundamental Screener
Screen Dr. Lal Path Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for LALPATHLAB shares.
Dr Lal PathLabs is a leading diagnostic healthcare service provider in India. The company operates a nationwide network of medical laboratory centers, offering over 5000 diagnostic tests and related healthcare services. Its infrastructure includes a National Reference Laboratory in New Delhi, Regional Reference Labs in Kolkata, Bangalore, and Mumbai, 371...more
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
Chairperson/CEO
Arvind Lal
ISIN
INE600L01024
Website
https://www.lalpathlabs.com
Dr. Lal Path Labs Balance Sheet Screener
Screen LALPATHLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,146 | 2,717 | 2,456 | 2,386 | 2,353 | 1,661 | 1,374 | 1,091 | 916 | 764 |
| Current Assets | 1,567 | 1,364 | 1,127 | 973 | 875 | 1,145 | 893 | 814 | 623 | 511 |
| Fixed Assets | 1,256 | 1,168 | 1,228 | 1,305 | 1,375 | 447 | 413 | 209 | 208 | 190 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 154 | 108 | 105 | 216 | 310 | 111 | 93 | 1 | 8 | 28 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,541 | 2,207 | 1,885 | 1,700 | 1,544 | 1,276 | 1,054 | 951 | 792 | 662 |
| Share Capital | 168 | 84 | 84 | 83 | 83 | 83 | 83 | 83 | 83 | 83 |
| Reserves & Surplus | 2,341 | 2,089 | 1,766 | 1,583 | 1,425 | 1,162 | 974 | 890 | 734 | 577 |
Dr. Lal Path Labs Income Statement Screener - Profit & Revenue Analysis
Screen Dr. Lal Path Labs income statement and profit fundamentals.
Analyze LALPATHLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dr. Lal Path Labs share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 727 | 830 | 628 | 698 | 755 | 684 | 564 | 623 | 682 | 622 | 505 | 555 | 619 | 557 | 498 |
| Expenses | 516 | 550 | 434 | 478 | 507 | 511 | 401 | 432 | 458 | 443 | 375 | 395 | 424 | 398 | 364 |
| EBITDA | 211 | 279 | 195 | 220 | 249 | 174 | 163 | 191 | 224 | 179 | 130 | 161 | 196 | 159 | 133 |
| Operating Profit % | 27.00% | 31.00% | 28.00% | 29.00% | 31.00% | 23.00% | 27.00% | 28.00% | 31.00% | 26.00% | 24.00% | 27.00% | 30.00% | 26.00% | 25.00% |
| Depreciation | 45 | 44 | 36 | 35 | 41 | 42 | 37 | 35 | 35 | 36 | 38 | 35 | 36 | 36 | 38 |
| Interest | 6 | 6 | 5 | 5 | 5 | 7 | 7 | 6 | 6 | 5 | 9 | 8 | 8 | 7 | 12 |
| Profit Before Tax | 160 | 229 | 153 | 181 | 204 | 124 | 120 | 150 | 183 | 138 | 83 | 118 | 152 | 116 | 84 |
| Tax | 28 | 58 | -2 | 47 | 51 | 33 | 34 | 42 | 52 | 40 | 26 | 34 | 42 | 34 | 21 |
| Net Profit | 132 | 171 | 156 | 134 | 152 | 91 | 86 | 108 | 131 | 98 | 57 | 84 | 111 | 82 | 62 |
| EPS | 7.86 | 10.15 | 18.57 | 15.88 | 18.05 | 5.42 | 10.13 | 12.79 | 15.52 | 11.60 | 6.84 | 9.95 | 13.16 | 9.77 | 7.41 |
Dr. Lal Path Labs Cash Flow Screener - Liquidity Fundamentals
Screen LALPATHLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 636 | 569 | 535 | 456 | 447 | 398 | 284 | 219 | 197 | 171 |
| Investing Activities | -422 | -303 | -24 | -287 | -449 | -212 | -26 | -100 | -172 | -137 |
| Financing Activities | -264 | -334 | -414 | -283 | 136 | -139 | -190 | -55 | 13 | -32 |
| Net Cash Flow | -50 | -68 | 97 | -115 | 134 | 48 | 67 | 64 | 37 | 2 |
Dr. Lal Path Labs Shareholding Pattern Screener
See Dr. Lal Path Labs shareholding pattern with promoter, FII, and DII holdings.
Check Dr. Lal Path Labs promoter holding and ownership changes for LALPATHLAB on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.19% | 53.21% | 53.21% | 53.21% | 53.79% | 53.91% | 53.91% | 53.92% |
| FII Holding | 17.36% | 17.18% | 20.29% | 21.86% | 21.68% | 23.91% | 26.82% | 26.82% |
| DII Holding | 21.59% | 21.38% | 19.21% | 18.49% | 17.91% | 16.08% | 13.17% | 12.89% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.25% | 6.54% | 5.82% | 5.19% | 5.23% | 4.11% | 4.01% | 4.10% |
| Other Holding | 1.60% | 1.67% | 1.47% | 1.25% | 1.38% | 2.00% | 2.10% | 2.27% |
| Shareholder Count | 111,037 | 114,527 | 114,385 | 112,703 | 118,656 | 115,699 | 116,236 | 116,606 |
Dr. Lal Path Labs Share Dividend Screener - Share Yield Analysis
Check Dr. Lal Path Labs dividend history with payout and yield data.
View Dr. Lal Path Labs dividend details including ex-dates and amounts for LALPATHLAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹20.50 | 1.07% |
| 2025-March | ₹24.00 | 1.83% |
| 2024-March | ₹24.00 | 1.94% |
| 2023-March | ₹12.00 | 1.06% |
| 2022-March | ₹12.00 | 1.31% |
| 2021-March | ₹20.00 | 1.53% |
| 2020-March | ₹12.00 | 0.89% |
| 2019-March | ₹6.00 | 0.86% |
| 2018-March | ₹4.50 | 0.86% |
| 2017-March | ₹3.00 | 0.68% |
Dr. Lal Path Labs Stock Index Membership
See which indices include Dr. Lal Path Labs stock.
Check LALPATHLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 100
NIFTY SMLCAP 250
NIFTY SMLCAP 50
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
Dr. Lal Path Labs Market Events Screener - Corporate Actions
Get Dr. Lal Path Labs corporate actions including splits, bonuses, and buybacks.
Check Dr. Lal Path Labs stock events that may affect LALPATHLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-30 | 2026-07-30 | Dividend | ₹ 5.00 /share | 11.59% |
| 2026-07-25 | 2026-07-25 | Annual General Meeting | NA | 25.88% |
| 2026-07-24 | 2026-07-24 | Quarterly Result Announcement | NA | -0.15% |
| 2026-06-25 | 2026-06-26 | Dividend | ₹ 4.00 /share | 20.87% |
| 2026-04-30 | 2026-04-30 | Quarterly Result Announcement | NA | 3.78% |
| 2026-02-05 | 2026-02-05 | Dividend | ₹ 3.50 /share | 0.85% |
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | -0.75% |
| 2025-12-19 | 2025-12-19 | Bonus | 1:1 | -3.25% |
| 2025-11-07 | 2025-11-07 | Dividend | ₹ 7.00 /share | 0.60% |
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 0.59% |
| 2025-08-06 | 2025-08-06 | Dividend | ₹ 6.00 /share | 3.08% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | 2.72% |
| 2025-06-28 | 2025-06-28 | Annual General Meeting | NA | -0.61% |
| 2025-06-06 | 2025-06-06 | Dividend | ₹ 6.00 /share | 2.46% |
| 2025-04-25 | 2025-04-25 | Quarterly Result Announcement | NA | 2.73% |
Dr. Lal Path Labs Competitors Screener - Peer Comparison
Screen LALPATHLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 32,116 | 58.66 | 2,864 | 12.11% | 510 | 53.50 |
| Vijaya Diagnostic Centre | 15,191 | 82.54 | 835 | 19.34% | 173 | 58.30 |
| Metropolis Healthcare | 12,009 | 59.91 | 1,671 | 24.15% | 191 | 54.18 |
| Thyrocare Technologies | 8,802 | 49.62 | 846 | 20.48% | 163 | 38.82 |
| Nephrocare Health Services | 7,417 | 90.61 | 1,023 | 32.93% | 77 | 68.67 |
| Krsnaa Diagnostics | 1,765 | 18.39 | 773 | 4.05% | 106 | 47.23 |
| Suraksha Diagnostic | 1,702 | 48.15 | 314 | 22.55% | 31 | 55.15 |
| 3B BlackBio DX | 1,198 | 21.72 | 142 | 27.17% | 61 | 56.62 |
| One Global Service Provider | 1,032 | 14.36 | 499 | 237.48% | 70 | 45.33 |
| Health X Platform | 958 | -37.44 | 1,319 | 12.68% | -3 | 55.59 |
Dr. Lal Path Labs Company Announcements - News Screener
Screen LALPATHLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-08-19 | Incorporation Of A Step-Down Subsidiary Company | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-07-26 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-25 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-07-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-24 | Corporate Action-Board approves Dividend | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-07-24 | Grant Of Stock Options | - |
| 2026-07-24 | The Record Date For The Purpose Of Payment Of Interim Dividend Shall Be July 30 2026 | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Dividend Updates | - |
| 2026-07-24 | Board Meeting Outcome for Outcome Of Board Meeting - July 24 2026 | - |
| 2026-07-24 | Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30 2026 | - |
| 2026-07-17 | Received An Appellate Order From Income Tax Department | - |